ORAVANCE
Live / Registered — Registered (as of 18 Jul 2023)
What this means for you
Registered since 18 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88338791
- Registration number
- 7115573
- Mark type
- Stylized text
- Filed
- 13 Mar 2019
- Published for opposition
- 17 Sept 2019
- Registered
- 18 Jul 2023
- Attorney of record
- Gregory B. Phillips
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of infections and infectious diseases, excluding those used for dental and tissue regeneration purposes; Antimicrobials preparations for the treatment and prevention of infections and infectious diseases, excluding those used for dental and tissue regeneration purposes
Owner
- QPEX BIOPHARMA, INC., San Diego, CA, US
- QPEX BIOPHARMA, INC., San Diego, CA, US
- QPEX BIOPHARMA, INC., San Diego, CA, US
Prosecution history
- 18 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 16 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jun 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Jun 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Jun 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 10 Mar 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 10 Mar 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 12 Dec 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Dec 2022 — NON-FINAL ACTION E-MAILED
- 12 Dec 2022 — SU - NON-FINAL ACTION - WRITTEN
- 14 Nov 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 11 Nov 2022 — USE AMENDMENT FILED
- 11 Nov 2022 — TEAS STATEMENT OF USE RECEIVED